See more : Light & Wonder, Inc. (LNW) Income Statement Analysis – Financial Results
Complete financial analysis of StemCell Institute Inc. (7096.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of StemCell Institute Inc., a leading company in the Biotechnology industry within the Healthcare sector.
- MFL India Limited (MFLINDIA.BO) Income Statement Analysis – Financial Results
- Better Life Commercial Chain Share Co.,Ltd (002251.SZ) Income Statement Analysis – Financial Results
- Century21 Real Estate of Japan Ltd (8898.T) Income Statement Analysis – Financial Results
- Asahi Concrete Works Co., Ltd. (5268.T) Income Statement Analysis – Financial Results
- ValOre Metals Corp. (KVLQF) Income Statement Analysis – Financial Results
StemCell Institute Inc. (7096.T)
About StemCell Institute Inc.
StemCell Institute Inc. engages in the stem cell banking business in Japan. The company is also involved in research and development of medical treatments using stem cells, as well as engages in banking of blood vessel cells businesses. StemCell Institute Inc. was incorporated in 1999 and is headquartered in Tokyo, Japan. StemCell Institute Inc. is a subsidiary of Trim Medical Holdings Inc.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 2.48B | 2.09B | 1.78B | 1.41B | 1.68B |
| Cost of Revenue | 905.31M | 755.45M | 670.69M | 485.31M | 543.00M |
| Gross Profit | 1.58B | 1.34B | 1.11B | 924.21M | 1.13B |
| Gross Profit Ratio | 63.51% | 63.88% | 62.36% | 65.57% | 67.60% |
| Research & Development | 11.42M | 9.00M | 9.00M | 8.00M | 3.00M |
| General & Administrative | 947.00M | 832.00M | 700.00M | 664.00M | 0.00 |
| Selling & Marketing | 196.00M | 194.00M | 175.00M | 166.00M | 0.00 |
| SG&A | 1.13B | 1.03B | 875.00M | 830.00M | 750.00M |
| Other Expenses | 9.00M | 935.00K | -9.29M | 5.43M | 0.00 |
| Operating Expenses | 1.16B | 1.04B | 884.31M | 837.33M | 751.00M |
| Cost & Expenses | 2.07B | 1.79B | 1.55B | 1.32B | 1.29B |
| Interest Income | 3.53M | 1.87M | 1.14M | 97.00K | 94.00K |
| Interest Expense | 0.00 | 0.00 | 27.00K | 0.00 | 0.00 |
| Depreciation & Amortization | 120.59M | 104.93M | 96.91M | 32.78M | -383.00M |
| EBITDA | 534.00M | 383.89M | 309.47M | 119.66M | -1.00M |
| EBITDA Ratio | 21.52% | 20.27% | 17.37% | 8.56% | -0.06% |
| Operating Income | 413.76M | 297.56M | 226.95M | 86.88M | 383.00M |
| Operating Income Ratio | 16.68% | 14.23% | 12.74% | 6.16% | 22.85% |
| Total Other Income/Expenses | 27.57M | -18.60M | -14.40M | 4.57M | 0.00 |
| Income Before Tax | 441.33M | 278.96M | 212.55M | 91.45M | 382.00M |
| Income Before Tax Ratio | 17.79% | 13.34% | 11.93% | 6.49% | 22.79% |
| Income Tax Expense | 130.35M | 80.92M | 78.83M | 29.07M | 105.00M |
| Net Income | 310.98M | 198.03M | 133.73M | 62.37M | 277.00M |
| Net Income Ratio | 12.53% | 9.47% | 7.50% | 4.42% | 16.53% |
| EPS | 30.25 | 19.33 | 13.20 | 6.41 | 28.46 |
| EPS Diluted | 30.25 | 19.33 | 13.20 | 6.41 | 27.03 |
| Weighted Avg Shares Out | 10.25M | 10.25M | 10.13M | 9.73M | 9.73M |
| Weighted Avg Shares Out (Dil) | 10.25M | 10.25M | 10.13M | 9.73M | 10.25M |
Source: https://incomestatements.info
Category: Stock Reports